Acute Bronchiolitis
23
3
3
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.3%
1 terminated out of 23 trials
90.9%
+4.4% vs benchmark
35%
8 trials in Phase 3/4
30%
3 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (23)
Risk Factors and Severity of Bronchiolitis in Hospitalized Children at Assiut University Hospital
Efficacy Of Combined Nebulized Hypertonic Saline and Chest Percussion Therapy in Acute Viral Bronchiolitis
Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care
High Flow Nasal Cannula Weaning in Acute Bronchiolitis
Nebulized 3% Hypertonic Saline Versus Normal Saline in Managing Children With Acute Bronchiolitis: A Randomized Controlled Trial
Viral Epidemiology of Bronchiolitis After Nirsevimab Implementation and Respiratory Evolution in Infants
Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis
Effects of Prone Positioning on Vital Parameters in Infants With Acute Bronchiolitis
Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis
Comparison of High Flow Nasal Cannula and Standard Face Mask Oxygen Therapy in Children With Bronchiolitis
Evaluation of the Effectiveness of Montelukast in Children With Recurrent Obstructive Bronchitis
Hypertonic Saline Inhalation in Acute Bronchiolitis
Evaluation of the Effects of Respiratory Physiotherapy in Infants With Moderate Acute Bronchiolitis
Acute Bronchiolitis in Infants and Allergic Asthma
Continuous Regional Analysis Device for Neonate Lung
Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis
Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department
Effect of Heliox on RSV Bronchiolitis
Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life
Acute Bronchiolitis and Severity Markers: Interest in Protein CC16